Study of gut bacteria in pancreatic cancer and precancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at the bacteria living in your gut and pancreas to understand how they might affect pancreatic cancer and precancerous changes. It is for people who are already scheduled for an endoscopic procedure to look at or treat a pancreatic lesion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or known growth in your pancreas (solid or fluid-filled).
- You are 18 years old or older.
- You are willing to sign a consent form.
- You do not have any bleeding or other health issues that would make an endoscopic procedure dangerous.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).
This study looks at differences in microbes (tiny organisms) using previously collected pancreatic tissue samples. It may help doctors understand how the microbiome relates to pancreatic diseases like pancreatic cancer.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This study looks at how changing the gut microbiome (gut bacteria) may help people with pancreatic cancer regain strength and slow or reverse cancer-related weight loss (cachexia). It also studies gut bacteria differences in people with pancreatic cancer who are losing weight versus those whose weight is stable, and in healthy volunteers.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.